The Bottom Line

Mohs surgery achieves a cure rate of up to 99% for first-time (primary) basal cell carcinomas — the highest of any treatment for this cancer. It works because the Mohs surgeon examines 100% of the surgical margins under a microscope before closing the wound, removing only tissue that contains cancer and leaving healthy skin intact. If you have a basal cell carcinoma in a high-risk location or an aggressive tumor subtype, Mohs surgery is almost certainly the treatment your dermatologist will recommend.

Why Does Mohs Surgery Have Such a High Cure Rate?

To understand why Mohs surgery is so effective for basal cell carcinoma (BCC), it helps to know the weakness of the alternatives.

In standard excision, the surgeon removes the tumor with a pre-set margin, sends it to a pathology lab, and closes the wound. The pathologist then examines a small sample — roughly 1–2% of the total margin surface. If cancer cells happen to be present in the areas that were not sampled, they are missed, and the patient may face a recurrence weeks or months later.

Mohs surgery eliminates this blind spot. After removing a thin horizontal layer of tissue, the Mohs surgeon personally maps the entire specimen, processes it on-site, and examines 100% of the undersurface and edges under the microscope — before the patient leaves the chair. If cancer is found at any edge, the surgeon removes another layer only in that specific location. This continues until all margins are clear. The result is complete cancer removal confirmed on the day of surgery.

Published five-year cure rates for BCC:

  • Mohs surgery for primary BCC: up to 99%
  • Mohs surgery for recurrent BCC: 94–95%
  • Standard excision for primary BCC: 89–92%
  • Electrodesiccation and curettage for low-risk BCC: 90–95%

What Is Basal Cell Carcinoma?

Basal cell carcinoma is the most common cancer in the United States, with an estimated 3.6 million new cases diagnosed each year. It arises from the basal cells — the deepest layer of the epidermis — and is almost always caused by cumulative ultraviolet (UV) radiation exposure. BCC grows slowly and very rarely spreads to other parts of the body, but it can cause significant local tissue destruction if left untreated.

BCC most commonly appears on sun-exposed areas: the face, nose, ears, scalp, neck, and hands. It often looks like a pearly or pink bump, a flat scar-like lesion, or a lesion with a rolled border and central depression that may bleed with minor trauma.

Which Basal Cell Carcinomas Are Best Treated with Mohs?

The American Academy of Dermatology (AAD) and the American Society for Dermatologic Surgery (ASDS) have developed guidelines that identify which BCCs are high-priority candidates for Mohs. These include:

  • Location on the head and neck — especially the “H-zone” of the face: around the eyes, nose, mouth, ears, and temples, where preserving tissue is critical for function and appearance
  • Aggressive BCC subtypes: Morpheaform, infiltrative, micronodular, or basosquamous BCCs, which grow with poorly defined borders and are at high risk of incomplete removal
  • Recurrent BCC: Any BCC that has returned after a prior treatment
  • Large BCCs: Tumors greater than 2 cm in diameter
  • Ill-defined clinical borders: When the edge of the tumor is hard to see even with dermoscopy
  • Perineural or perivascular invasion: Found on pathology, indicating deeper or more aggressive spread
  • Immunocompromised patients: Including organ transplant recipients and those on long-term immunosuppressive therapy

What to Expect on the Day of Mohs Surgery

Mohs surgery for BCC is done in a specialized outpatient clinic — you are awake the entire time and go home the same day. Here is how the day typically unfolds:

  • Preparation: The site is cleaned and draped. Local anesthesia (lidocaine with epinephrine) is injected around the tumor. This stings briefly, then the area is completely numb.
  • Stage 1 — tissue removal: The visible tumor is removed along with a thin first layer (stage) of tissue. The surgeon maps and color-codes the specimen edges.
  • Processing (waiting period): The tissue is processed and cut into frozen sections in the on-site lab, stained, and examined under the microscope. This takes approximately 45–60 minutes per stage. You wait comfortably in the clinic.
  • Results and decision: If cancer remains at any edge, another targeted layer is removed only from that specific location.
  • Repeat stages: The average BCC requires 1.5–2 stages. About 80% of cases are clear after just one stage.
  • Reconstruction: Once all margins are clear, the wound is repaired. Depending on size and location, this may involve direct suture closure, a skin flap, a skin graft, or second-intention healing.
  • Total time: Plan for a half to full day — typically 3–6 hours including waiting time.

Recovery After Mohs for BCC

  • Pain: Usually mild — over-the-counter acetaminophen manages it for most patients. Avoid aspirin and NSAIDs for 48 hours unless medically necessary.
  • Wound care: Daily cleaning with mild soap and water, then petroleum jelly and a fresh bandage. Written instructions will be provided at your appointment.
  • Swelling and bruising: Common around the eyes and nose for 5–10 days. Sleeping with your head elevated helps reduce swelling.
  • Activity: Avoid strenuous exercise for 2–4 weeks to protect the repair.
  • Suture removal: 5–14 days post-op, depending on location.
  • Follow-up surveillance: A new BCC develops in a different location in about 40% of patients within 5 years. Annual full-body skin exams are essential.

When to See a Dermatologist

  • You notice a pearly, pink, or translucent bump — especially on the face, scalp, or neck
  • You have a sore that bleeds easily, forms a crust, and does not fully heal within 4–6 weeks
  • You were previously treated for BCC and notice a growth returning at or near the scar
  • You have a history of significant sun exposure, tanning bed use, or prior organ transplant
  • You want to discuss whether Mohs surgery is the right choice for your specific BCC

Frequently Asked Questions

Why is Mohs surgery not used for every BCC?

Mohs surgery is more resource-intensive than standard excision. It requires a trained Mohs surgeon with on-site histology capabilities, and each case takes several hours. For low-risk BCCs in non-critical locations (for example, a small nodular BCC on the back), standard excision or ED&C provides excellent cure rates at lower cost and shorter procedure time. Mohs is reserved for situations where its precision provides a meaningful benefit.

Will insurance cover Mohs surgery for BCC?

In most cases, yes. Medicare and most private insurers cover Mohs surgery when performed for a cancer that meets the clinical criteria for the procedure. Verify your specific coverage before surgery. The Mohs surgeon’s office can assist with pre-authorization if needed.

What if my BCC needs more than one stage?

Multiple stages are common for larger tumors, aggressive subtypes, or cancers in areas with complex anatomy. Each additional stage adds roughly 45–60 minutes to your wait time. While this can make for a long day, the trade-off is confirmation that every last cancer cell has been removed before you leave — something no other outpatient technique offers.

Is there anything that can replace Mohs surgery for high-risk BCC?

For patients who cannot undergo surgery, radiation therapy is an effective alternative with cure rates of 85–95% for primary BCC. Vismodegib (Erivedge) and sonidegib (Odomzo) are targeted oral medications approved for locally advanced or metastatic BCC that cannot be surgically removed. However, for the vast majority of patients with high-risk BCC, Mohs surgery remains the gold standard.

References

  1. Rowe DE, et al. Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. J Dermatol Surg Oncol. 1989;15(3):315-328.
  2. Mosterd K, et al. Surgical excision versus Mohs’ micrographic surgery for primary and recurrent basal-cell carcinoma of the face. Lancet Oncol. 2008;9(2):149-156.
  3. Connolly SM, et al. AAD/ACMS/ASDSA/ASMS 2012 Appropriate Use Criteria for Mohs Micrographic Surgery. J Am Acad Dermatol. 2012;67(4):531-550.
  4. National Comprehensive Cancer Network (NCCN). Basal Cell Skin Cancer. Version 2024.
  5. American College of Mohs Surgery. Mohs Surgery for Basal Cell Carcinoma. ACMS.org.

Trusted Resources

Always consult a board-certified dermatologist or Mohs surgeon for evaluation and treatment of basal cell carcinoma. This article is for educational purposes only and does not replace professional medical advice.